Health Care: Drugs

Vanda Pharmaceuticals Inc (VNDA: NASDAQ)

$8.64 n/a | n/a%
02/05/16 - 03:59 PM ET
Company Profile
Price and Volume
Recent Price 8.64
52 Week High 14.50
52 Week Low 8.00
Avg. Daily Vol. (Mil) 0.67
Beta (3 year) 1.69
Share Related Items
Mkt Cap (Mil) 369.92
Shares Out (Mil) 42.82
Float (Mil) 41.16
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 3.50
Current Ratio 3.80
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings 6.10
Price/Sales 3.96
Price/Book 2.53
Price/Cash Flow 6.60
Per Share Data
Earnings 1.42
Sales 2.18
Book Value 3.41
Cash Flow 1.32
Business Summary
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of products for the treatment of central nervous system disorders such as HETLIOZ, Fanapt and VLY-686.
General Information
2200 Pennsylvania Avenue NW
Suite 300 E
Washington, DC 20037
Industry : Drugs
Sector: Health Care
Employees: 64
CEO: Dr. Mihael Hristos Polym
Short Interest
Current Month (Mil) 8.10
Previous Month (Mil) 7.83
Short Interest Ratio (Days) 10.40
Management Effectiveness
Return on Equity 30.60
Return on Assets 20.20
Return on Investments 30.60
Gross Margin 82.10
EBIT Margin 47.80
Profit Margin 47.80

Portfolios with VNDA

Latest VNDA Headlines from TheStreet

More Financial News for VNDA

Press Releases for VNDA

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter